News China to accept overseas clinical trial data The Chinese government has announced plans to accept data from clinical trials carried out overseas, in order to speed up approvals.
News No cardio protection indication for Novo's semaglutide - yet Danish pharma plans outcome trial to confirm benefits in SUSTAIN 6
News PureTech's device could rival Saxenda in obesity market A new non-invasive device from PureTech Health could help millions of overweight or obese people to slim down, allowing them to avoid surgery or prescription treatments.
News Novo aims for GLP-1 sales growth in China Novo expects Victoza and semaglutide to gain momentum.
Views & Analysis Pharma 2022: big pharma will remain a constant Pharma 2022: big pharma to maintain its position, ready to pounce on any newcomer that shows promise.
News AI specialists Enveda and Basecamp rake in the cash AI-powered drug discovery companies Enveda and Basecamp have completed impressive funding rounds, worth $311m and $140m, respectively.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
